Livelsberger Financial Advisory’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-75	Closed	-$1.15K	–	14
2024 Q1	$1.15K	Hold	75	–	–	0.01%	15
2023 Q4	$2.35K	Buy	+75	New	+$2.35K	﹤0.01%	381